BioSpace News Archive

If you purchased OWC Pharmaceutical Research Corp. stock between November 2016 and September 2017, you may be eligible for distribution from the Jeffrey Friedland Fair Fund

Altamira Therapeutics Ltd. today announced that it has established a new business unit, OTC Consumer Health, to support the ongoing global roll out of Bentrio.

Amolyt Pharma today announced that the company has been selected for the French Tech FT120.

BioMarin Pharmaceutical Inc. today announced that the Company presented positive results from a two-year analysis of the Phase 3 GENEr8-1 study.

In December 2021, imtmedical ag, a subsidiary of Vyaire Medical, initiated a voluntary field correction for certain bellavista™ ventilators.

When the Omicron variant first began to spread throughout the US, Premier Medical Laboratory Services (PMLS) identified one of the first cases in South Carolina through Next Generation Sequencing.

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that the Compensation Committee of the Company’s Board of Directors approved a new employment inducement grant of stock options to purchase 150,000 shares of common stock with a grant date of January 31, 2022 to one new employee.

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to eighteen new employees.

Ardelyx, Inc. today announced that on February 1, 2022 , the compensation committee of the company’s board of directors granted four new non-executive employees.

Provention Bio, Inc. today announced that the Company granted stock options on February 1, 2022 to a new non-executive employee to purchase an aggregate of 30,000 shares of common stock.